Atomoxetine is indicated for treating attention deficit hyperactivity disorder (ADHD) in adults and children over six years. Although atomoxetine is only FDA-approved for treating ADHD, it is sometimes used off-label to treat adult patients with treatment-resistant depression. This activity outlines the indications, mechanism of action, administration, adverse effects, contraindications, and monitoring of atomoxetine.

**Objectives:**
- Identify the mechanism of action of atomoxetine.
- Outline the contraindications of atomoxetine.
- Review the appropriate follow-up monitoring for atomoxetine therapy.
- Summarize some interprofessional team strategies for improving care coordination and communication to enhance patient outcomes and minimize adverse events with atomoxetine.